Topline data were announced from a phase 3 trial evaluating ecopipam in pediatric and adult patients with Tourette syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback